Differential changes in maternal proinflammatory IL6 plasmalevels as a putatively surrogate marker of candidacy andclinical utility during mid- and late pregnancy hyperglycemia:interventional impact of clinical pharmacist on maternal andneonatal outcomes in a randomized clinical trial. Pharm Pract (Granada) [Internet]. 2024 Mar. 6 [cited 2025 Oct. 22];22(1). Available from: https://pharmacypractice.org/index.php/pp/article/view/2881